Chris Goppelsroeder, currently president and CEO of DSM Nutritional Products (DNP) and member of the DSM Executive Committee, will retire and leave the company on April 1, 2021.
Dimitri de Vreeze, DSM's Co-CEO, will step into Chris' DNP leadership role in his capacity as COO.
The company said that Goppelsroeder has had a long and successful career at DSM, having first joined in 2003 when DSM acquired Roche Holding AG's vitamins division. In 2013, he took on his current role.
“Since then, he has led DSM's largest business to above-market growth and transformed its operating model to a customer-centric innovation powerhouse that is a world leader in health through nutrition. He was instrumental in DNP's growth organically as well as through acquisitions, including recently Glycom and the Erber Group.
“In addition, Chris played a crucial role in the development of big innovation projects such as Clean Cow/Bovaer, Veramaris and DSM's new moves in the space of precision and personalized nutrition.”
DSM Co-CEO, Geraldine Matchett, along with de Vreeze, said "Chris leaves a tremendous legacy and, on behalf of the entire company, we wish him all the best for his well-deserved retirement."